Operating Lease, Liability of Sagimet Biosciences Inc. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Sagimet Biosciences Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
Sagimet Biosciences Inc. Operating Lease, Liability for the quarter ending 31 Dec 2024 was $78,000, a 20% increase year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Sagimet Biosciences Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$78,000	+$13,000	+20%	31 Dec 2024	10-K	12 Mar 2025	2024	FY
Q4 2023	$65,000	-$146,000	-69%	31 Dec 2023	10-K	25 Mar 2024	2023	FY
Q3 2023	$103,000			30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$140,000			30 Jun 2023	10-Q	21 Aug 2023	2023	Q2
Q4 2022	$211,000			31 Dec 2022	10-Q	13 Nov 2023	2023	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.